Skip to main content
Top
Published in: AIDS Research and Therapy 1/2022

Open Access 01-12-2022 | Human Immunodeficiency Virus | Research

PrEP-related stigma and PrEP use among gay, bisexual and other men who have sex with men in Ontario and British Columbia, Canada

Authors: Oscar Javier Pico-Espinosa, Mark Hull, Paul MacPherson, Daniel Grace, Mark Gaspar, Nathan Lachowsky, Saira Mohammed, James Demers, Marshall Kilduff, Robinson Truong, Darrell H. S. Tan

Published in: AIDS Research and Therapy | Issue 1/2022

Login to get access

Abstract

Background

We aimed to explore the association between PrEP-related stereotypes and perceived disapproval (hereafter PrEP-related stigma), and PrEP use.

Methods

We used data from a cross-sectional online survey among adult gay, bisexual, other men who have sex with men in Ontario and British Columbia, Canada. Participants were recruited 2019–2020 in-person from sexual health clinics and outreach programs, and online through dating mobile applications and websites. We used logistic regression models to explore the relationship between PrEP-related stigma and: 1-being a ‘never’ versus ‘current’ PrEP user, and 2-being a ‘former’ versus ‘current’ user.

Results

The median age of the sample was 32 (Q1-Q3 = 27–40), most were white born in Canada (48%), 45% had never used PrEP, 16% were former PrEP users and 39% were current PrEP users. Of 1527 individuals who started the survey, 1190 participants answered questions about PrEP-related stigma: 254 (21.3%) were classified as having low level of PrEP-related stigma, 776 (65.2%) intermediate, and 160 (13.5%) high. No significant association was found when never PrEP users and current PrEP users were compared: adjusted OR = 1.44 (95%-CI: 0.8–2.5). High PrEP-related stigma was positively associated with being a former PrEP user compared to being a current PrEP user: adjusted OR = 2.5 (95%-CI: 1.3–4.9).

Conclusion

PrEP-related stigma is associated with not using PrEP, particularly with PrEP discontinuation. Our findings indicate that stigma persists as a barrier to PrEP use.
Appendix
Available only for authorised users
Literature
2.
go back to reference Grant R, Lama J, Anderson P, McMahan V, Liu A, Vargas L, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. New England Journal of Medicine. 2010(363):2587–99. Grant R, Lama J, Anderson P, McMahan V, Liu A, Vargas L, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. New England Journal of Medicine. 2010(363):2587–99.
3.
go back to reference Mayer KH, Molina J-M, Thompson MA, Anderson PL, Mounzer KC, De Wet JJ, et al. Emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis (DISCOVER): primary results from a randomised, double-blind, multicentre, active-controlled, phase 3, non-inferiority trial. The Lancet. 2020;396(10246):239–54.CrossRef Mayer KH, Molina J-M, Thompson MA, Anderson PL, Mounzer KC, De Wet JJ, et al. Emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis (DISCOVER): primary results from a randomised, double-blind, multicentre, active-controlled, phase 3, non-inferiority trial. The Lancet. 2020;396(10246):239–54.CrossRef
4.
go back to reference Tan DHS, Hull MW, Yoong D, Tremblay C, O’Byrne P, Thomas R, et al. Canadian guideline on HIV pre-exposure prophylaxis and nonoccupational postexposure prophylaxis. CMAJ. 2017;189(47):E1448-E58.CrossRef Tan DHS, Hull MW, Yoong D, Tremblay C, O’Byrne P, Thomas R, et al. Canadian guideline on HIV pre-exposure prophylaxis and nonoccupational postexposure prophylaxis. CMAJ. 2017;189(47):E1448-E58.CrossRef
5.
go back to reference Grant RM, Anderson PL, McMahan V, Liu A, Amico KR, Mehrotra M, et al. Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study. Lancet Infect Dis. 2014;14(9):820–9.CrossRefPubMedPubMedCentral Grant RM, Anderson PL, McMahan V, Liu A, Amico KR, Mehrotra M, et al. Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study. Lancet Infect Dis. 2014;14(9):820–9.CrossRefPubMedPubMedCentral
6.
go back to reference Grulich A, Guy R, Amin J, FengyiJin F, Selvey C, Holden J. Population-level effectiveness of rapid, targeted, high-coverage roll-out of HIV pre-exposure prophylaxis in men who have sex with men: the EPIC-NSW prospective cohort study. The Lancet. 2018;5(11):e629-e37. Grulich A, Guy R, Amin J, FengyiJin F, Selvey C, Holden J. Population-level effectiveness of rapid, targeted, high-coverage roll-out of HIV pre-exposure prophylaxis in men who have sex with men: the EPIC-NSW prospective cohort study. The Lancet. 2018;5(11):e629-e37.
7.
go back to reference Philbin MM, Parker CM, Parker RG, Wilson PA, Garcia J, Hirsch JS. The Promise of Pre-Exposure Prophylaxis for Black Men Who Have Sex with Men: An Ecological Approach to Attitudes, Beliefs, and Barriers. AIDS Patient Care STDS. 2016;30(6):282–90.CrossRefPubMedPubMedCentral Philbin MM, Parker CM, Parker RG, Wilson PA, Garcia J, Hirsch JS. The Promise of Pre-Exposure Prophylaxis for Black Men Who Have Sex with Men: An Ecological Approach to Attitudes, Beliefs, and Barriers. AIDS Patient Care STDS. 2016;30(6):282–90.CrossRefPubMedPubMedCentral
8.
go back to reference Weiss MG, Ramakrishna J. Stigma interventions and research for international health. The Lancet. 2006;367(9509):536–8.CrossRef Weiss MG, Ramakrishna J. Stigma interventions and research for international health. The Lancet. 2006;367(9509):536–8.CrossRef
9.
go back to reference Goffman E. Stigma: Notes on the Management of Spoiled Identity. Schuster S, editor. New York, NY1963. 168 p. Goffman E. Stigma: Notes on the Management of Spoiled Identity. Schuster S, editor. New York, NY1963. 168 p.
10.
go back to reference Turan B, Hatcher AM, Weiser SD, Johnson MO, Rice WS, Turan JM. Framing Mechanisms Linking HIV-Related Stigma, Adherence to Treatment, and Health Outcomes. Am J Public Health. 2017;107(6):863–9.CrossRefPubMedPubMedCentral Turan B, Hatcher AM, Weiser SD, Johnson MO, Rice WS, Turan JM. Framing Mechanisms Linking HIV-Related Stigma, Adherence to Treatment, and Health Outcomes. Am J Public Health. 2017;107(6):863–9.CrossRefPubMedPubMedCentral
11.
go back to reference Rosengren AL, Lelutiu-Weinberger C, Woodhouse EW, Sandanapitchai P, Hightow-Weidman LB. A Scoping Review of HIV Pre-exposure Prophylaxis Stigma and Implications for Stigma-Reduction Interventions for Men and Transwomen Who Have Sex with Men. AIDS Behav. 2021. Rosengren AL, Lelutiu-Weinberger C, Woodhouse EW, Sandanapitchai P, Hightow-Weidman LB. A Scoping Review of HIV Pre-exposure Prophylaxis Stigma and Implications for Stigma-Reduction Interventions for Men and Transwomen Who Have Sex with Men. AIDS Behav. 2021.
12.
13.
go back to reference Grace D, Jollimore J, MacPherson P, Strang MJP, Tan DHS. The Pre-Exposure Prophylaxis-Stigma Paradox: Learning from Canada’s First Wave of PrEP Users. AIDS Patient Care STDS. 2018;32(1):24–30.CrossRefPubMedPubMedCentral Grace D, Jollimore J, MacPherson P, Strang MJP, Tan DHS. The Pre-Exposure Prophylaxis-Stigma Paradox: Learning from Canada’s First Wave of PrEP Users. AIDS Patient Care STDS. 2018;32(1):24–30.CrossRefPubMedPubMedCentral
14.
go back to reference Calabrese SK, Underhill K. How Stigma Surrounding the Use of HIV Preexposure Prophylaxis Undermines Prevention and Pleasure: A Call to Destigmatize “Truvada Whores”. Am J Public Health. 2015;105(10):1960–4.CrossRefPubMedPubMedCentral Calabrese SK, Underhill K. How Stigma Surrounding the Use of HIV Preexposure Prophylaxis Undermines Prevention and Pleasure: A Call to Destigmatize “Truvada Whores”. Am J Public Health. 2015;105(10):1960–4.CrossRefPubMedPubMedCentral
15.
go back to reference Gagliano N, Black S, Mniszak C, Morgan J, Lachowsky N, Knight R. Exchanging a “Gnawing Thought for “Taking a Pill Once a Day”: Examining Sexual Minority Men’s Experiences With PrEP and Mental Health in a Universal PrEP Access Context. AIDS Educ Prev. 2021;33(5):411–23.CrossRefPubMed Gagliano N, Black S, Mniszak C, Morgan J, Lachowsky N, Knight R. Exchanging a “Gnawing Thought for “Taking a Pill Once a Day”: Examining Sexual Minority Men’s Experiences With PrEP and Mental Health in a Universal PrEP Access Context. AIDS Educ Prev. 2021;33(5):411–23.CrossRefPubMed
16.
go back to reference Calabrese SK. Understanding, Contextualizing, and Addressing PrEP Stigma to Enhance PrEP Implementation. Curr HIV/AIDS Rep. 2020;17(6):579–88.CrossRefPubMed Calabrese SK. Understanding, Contextualizing, and Addressing PrEP Stigma to Enhance PrEP Implementation. Curr HIV/AIDS Rep. 2020;17(6):579–88.CrossRefPubMed
17.
go back to reference Dubov A, Galbo P Jr, Altice FL, Fraenkel L. Stigma and Shame Experiences by MSM Who Take PrEP for HIV Prevention: A Qualitative Study. Am J Mens Health. 2018;12(6):1843–54.CrossRefPubMedPubMedCentral Dubov A, Galbo P Jr, Altice FL, Fraenkel L. Stigma and Shame Experiences by MSM Who Take PrEP for HIV Prevention: A Qualitative Study. Am J Mens Health. 2018;12(6):1843–54.CrossRefPubMedPubMedCentral
18.
go back to reference Reyniers T, Zimmermann HML, Davidovich U, Vuylsteke B, Laga M, Hoornenborg E, et al. The social meanings of PrEP use – A mixed-method study of PrEP use disclosure in Antwerp and Amsterdam. Sociology of Health & Illness; 2021. Reyniers T, Zimmermann HML, Davidovich U, Vuylsteke B, Laga M, Hoornenborg E, et al. The social meanings of PrEP use – A mixed-method study of PrEP use disclosure in Antwerp and Amsterdam. Sociology of Health & Illness; 2021.
19.
go back to reference Sidebottom D, Ekstrom AM, Stromdahl S. A systematic review of adherence to oral pre-exposure prophylaxis for HIV - how can we improve uptake and adherence? BMC Infect Dis. 2018;18(1):581.CrossRefPubMedPubMedCentral Sidebottom D, Ekstrom AM, Stromdahl S. A systematic review of adherence to oral pre-exposure prophylaxis for HIV - how can we improve uptake and adherence? BMC Infect Dis. 2018;18(1):581.CrossRefPubMedPubMedCentral
20.
go back to reference Matacotta JJ, Rosales-Perez FJ, Carrillo CM. HIV Preexposure Prophylaxis and Treatment as Prevention - Beliefs and Access Barriers in Men Who Have Sex With Men (MSM) and Transgender Women: A Systematic Review. J Patient Cent Res Rev. 2020;7(3):265–74.CrossRefPubMedPubMedCentral Matacotta JJ, Rosales-Perez FJ, Carrillo CM. HIV Preexposure Prophylaxis and Treatment as Prevention - Beliefs and Access Barriers in Men Who Have Sex With Men (MSM) and Transgender Women: A Systematic Review. J Patient Cent Res Rev. 2020;7(3):265–74.CrossRefPubMedPubMedCentral
21.
go back to reference Peng P, Su S, Fairley CK, Chu M, Jiang S, Zhuang X, et al. A Global Estimate of the Acceptability of Pre-exposure Prophylaxis for HIV Among Men Who have Sex with Men: A Systematic Review and Meta-analysis. AIDS Behav. 2018;22(4):1063–74.CrossRefPubMed Peng P, Su S, Fairley CK, Chu M, Jiang S, Zhuang X, et al. A Global Estimate of the Acceptability of Pre-exposure Prophylaxis for HIV Among Men Who have Sex with Men: A Systematic Review and Meta-analysis. AIDS Behav. 2018;22(4):1063–74.CrossRefPubMed
22.
go back to reference Pleuhs B, Quinn KG, Walsh JL, Petroll AE, John SA. Health Care Provider Barriers to HIV Pre-Exposure Prophylaxis in the United States: A Systematic Review. AIDS Patient Care STDS. 2020;34(3):111–23.CrossRefPubMedPubMedCentral Pleuhs B, Quinn KG, Walsh JL, Petroll AE, John SA. Health Care Provider Barriers to HIV Pre-Exposure Prophylaxis in the United States: A Systematic Review. AIDS Patient Care STDS. 2020;34(3):111–23.CrossRefPubMedPubMedCentral
23.
go back to reference Eaton LA, Kalichman SC, Price D, Finneran S, Allen A, Maksut J. Stigma and Conspiracy Beliefs Related to Pre-exposure Prophylaxis (PrEP) and Interest in Using PrEP Among Black and White Men and Transgender Women Who Have Sex with Men. AIDS Behav. 2017;21(5):1236–46.CrossRefPubMedPubMedCentral Eaton LA, Kalichman SC, Price D, Finneran S, Allen A, Maksut J. Stigma and Conspiracy Beliefs Related to Pre-exposure Prophylaxis (PrEP) and Interest in Using PrEP Among Black and White Men and Transgender Women Who Have Sex with Men. AIDS Behav. 2017;21(5):1236–46.CrossRefPubMedPubMedCentral
24.
go back to reference Kerr J, Ayangeakaa S, Bullock NAA, Burton K, Combs R, Harris L, et al. A Qualitative Exploration of Various Stigmas Impacting HIV Pre-Exposure Prophylaxis (PrEP) Uptake Among African American Young Adults. Fam Community Health. 2022;45(4):218–27.CrossRefPubMed Kerr J, Ayangeakaa S, Bullock NAA, Burton K, Combs R, Harris L, et al. A Qualitative Exploration of Various Stigmas Impacting HIV Pre-Exposure Prophylaxis (PrEP) Uptake Among African American Young Adults. Fam Community Health. 2022;45(4):218–27.CrossRefPubMed
26.
go back to reference Wilton J, Kain T, Fowler S, Hart TA, Grennan T, Maxwell J, et al. Use of an HIV-risk screening tool to identify optimal candidates for PrEP scale-up among men who have sex with men in Toronto, Canada: disconnect between objective and subjective HIV risk. J Int AIDS Soc. 2016;19(1):20777.CrossRefPubMedPubMedCentral Wilton J, Kain T, Fowler S, Hart TA, Grennan T, Maxwell J, et al. Use of an HIV-risk screening tool to identify optimal candidates for PrEP scale-up among men who have sex with men in Toronto, Canada: disconnect between objective and subjective HIV risk. J Int AIDS Soc. 2016;19(1):20777.CrossRefPubMedPubMedCentral
27.
go back to reference Kimball D, Rivera D, Gonzales Mt, Blashill AJ. Medical Mistrust and the PrEP Cascade Among Latino Sexual Minority Men. AIDS Behav. 2020;24(12):3456–61.CrossRefPubMedPubMedCentral Kimball D, Rivera D, Gonzales Mt, Blashill AJ. Medical Mistrust and the PrEP Cascade Among Latino Sexual Minority Men. AIDS Behav. 2020;24(12):3456–61.CrossRefPubMedPubMedCentral
28.
go back to reference Quinn K, Dickson-Gomez J, Zarwell M, Pearson B, Lewis M. “A Gay Man and a Doctor are Just like, a Recipe for Destruction”: How Racism and Homonegativity in Healthcare Settings Influence PrEP Uptake Among Young Black MSM. AIDS Behav. 2019;23(7):1951–63.CrossRefPubMedPubMedCentral Quinn K, Dickson-Gomez J, Zarwell M, Pearson B, Lewis M. “A Gay Man and a Doctor are Just like, a Recipe for Destruction”: How Racism and Homonegativity in Healthcare Settings Influence PrEP Uptake Among Young Black MSM. AIDS Behav. 2019;23(7):1951–63.CrossRefPubMedPubMedCentral
29.
go back to reference Kota KK, Mansergh G, Stephenson R, Hirshfield S, Sullivan P. Sociodemographic Characteristics of HIV Pre-Exposure Prophylaxis Use and Reasons for Nonuse Among Gay, Bisexual, and Other Men Who Have Sex with Men from Three US Cities. AIDS Patient Care STDS; 2021. Kota KK, Mansergh G, Stephenson R, Hirshfield S, Sullivan P. Sociodemographic Characteristics of HIV Pre-Exposure Prophylaxis Use and Reasons for Nonuse Among Gay, Bisexual, and Other Men Who Have Sex with Men from Three US Cities. AIDS Patient Care STDS; 2021.
30.
go back to reference Gaspar M, Salway T, Grace D. Ambivalence and the biopolitics of HIV pre-exposure prophylaxis (PrEP) implementation. Soc Theory Health. 2021:1–17. Gaspar M, Salway T, Grace D. Ambivalence and the biopolitics of HIV pre-exposure prophylaxis (PrEP) implementation. Soc Theory Health. 2021:1–17.
31.
go back to reference Smith DK, Pals SL, Herbst JH, Shinde S, Carey JW. Development of a Clinical Screening Index Predictive of Incident HIV Infection Among Men Who Have Sex With Men in the United States. J Acquir Immune Defic Syndr. 2012;60(4):421–7.CrossRefPubMed Smith DK, Pals SL, Herbst JH, Shinde S, Carey JW. Development of a Clinical Screening Index Predictive of Incident HIV Infection Among Men Who Have Sex With Men in the United States. J Acquir Immune Defic Syndr. 2012;60(4):421–7.CrossRefPubMed
32.
go back to reference Wilson K, Bleasdale J, Przybyla SM. Provider-Patient Communication on Pre-Exposure Prophylaxis (Prep) for HIV Prevention: An Exploration of Healthcare Provider Challenges. Health Commun. 2020:1–10. Wilson K, Bleasdale J, Przybyla SM. Provider-Patient Communication on Pre-Exposure Prophylaxis (Prep) for HIV Prevention: An Exploration of Healthcare Provider Challenges. Health Commun. 2020:1–10.
33.
go back to reference Mehrotra ML, Rivet Amico K, McMahan V, Glidden DV, Defechereux P, Guanira JV, et al. The Role of Social Relationships in PrEP Uptake and Use Among Transgender Women and Men Who Have Sex with Men. AIDS Behav. 2018;22(11):3673–80.CrossRefPubMedPubMedCentral Mehrotra ML, Rivet Amico K, McMahan V, Glidden DV, Defechereux P, Guanira JV, et al. The Role of Social Relationships in PrEP Uptake and Use Among Transgender Women and Men Who Have Sex with Men. AIDS Behav. 2018;22(11):3673–80.CrossRefPubMedPubMedCentral
34.
go back to reference Jaiswal J, LoSchiavo C, Meanley S, Hascher K, Cox AB, Dunlap KB, et al. Correlates of PrEP Uptake Among Young Sexual Minority Men and Transgender Women in New York City: The Need to Reframe “Risk” Messaging and Normalize Preventative Health. AIDS Behav. 2021;25(10):3057–73.CrossRefPubMedPubMedCentral Jaiswal J, LoSchiavo C, Meanley S, Hascher K, Cox AB, Dunlap KB, et al. Correlates of PrEP Uptake Among Young Sexual Minority Men and Transgender Women in New York City: The Need to Reframe “Risk” Messaging and Normalize Preventative Health. AIDS Behav. 2021;25(10):3057–73.CrossRefPubMedPubMedCentral
35.
go back to reference StataCorp. Stata Statistical Software: Release 16. In: LLC S, editor. College Station, TX2019. StataCorp. Stata Statistical Software: Release 16. In: LLC S, editor. College Station, TX2019.
36.
go back to reference Laborde ND, Kinley PM, Spinelli M, Vittinghoff E, Whitacre R, Scott HM, et al. Understanding PrEP Persistence: Provider and Patient Perspectives. AIDS Behav. 2020;24(9):2509–19.CrossRefPubMedPubMedCentral Laborde ND, Kinley PM, Spinelli M, Vittinghoff E, Whitacre R, Scott HM, et al. Understanding PrEP Persistence: Provider and Patient Perspectives. AIDS Behav. 2020;24(9):2509–19.CrossRefPubMedPubMedCentral
37.
go back to reference Greenwald Z, Beauchemin M, Benomar K, Landry G, Boissonnault M, Charest L et al, editors. High seroconversion rates following PrEP discontinuance in a Montreal Clinic. Conference on Retroviruses and Opportunistic Infections (CROI); 2018 March 4–7; Boston, MA. Greenwald Z, Beauchemin M, Benomar K, Landry G, Boissonnault M, Charest L et al, editors. High seroconversion rates following PrEP discontinuance in a Montreal Clinic. Conference on Retroviruses and Opportunistic Infections (CROI); 2018 March 4–7; Boston, MA.
38.
go back to reference Arnold T, Brinkley-Rubinstein L, Chan PA, Perez-Brumer A, Bologna ES, Beauchamps L, et al. Social, structural, behavioral and clinical factors influencing retention in Pre-Exposure Prophylaxis (PrEP) care in Mississippi. PLoS ONE. 2017;12(2):e0172354.CrossRefPubMedPubMedCentral Arnold T, Brinkley-Rubinstein L, Chan PA, Perez-Brumer A, Bologna ES, Beauchamps L, et al. Social, structural, behavioral and clinical factors influencing retention in Pre-Exposure Prophylaxis (PrEP) care in Mississippi. PLoS ONE. 2017;12(2):e0172354.CrossRefPubMedPubMedCentral
39.
go back to reference Brown G, Leonard W, Lyons A, Power J, Sander D, McColl W, et al. Stigma, gay men and biomedical prevention: the challenges and opportunities of a rapidly changing HIV prevention landscape. Sex Health. 2017;14(1):111–8.CrossRefPubMed Brown G, Leonard W, Lyons A, Power J, Sander D, McColl W, et al. Stigma, gay men and biomedical prevention: the challenges and opportunities of a rapidly changing HIV prevention landscape. Sex Health. 2017;14(1):111–8.CrossRefPubMed
40.
go back to reference Calabrese SK, Dovidio JF, Tekeste M, Taggart T, Galvao RW, Safon CB, et al. HIV Pre-Exposure Prophylaxis Stigma as a Multidimensional Barrier to Uptake Among Women Who Attend Planned Parenthood. J Acquir Immune Defic Syndr. 2018;79(1):46–53.CrossRefPubMedPubMedCentral Calabrese SK, Dovidio JF, Tekeste M, Taggart T, Galvao RW, Safon CB, et al. HIV Pre-Exposure Prophylaxis Stigma as a Multidimensional Barrier to Uptake Among Women Who Attend Planned Parenthood. J Acquir Immune Defic Syndr. 2018;79(1):46–53.CrossRefPubMedPubMedCentral
41.
go back to reference Siegler AJ, Wiatrek S, Mouhanna F, Amico KR, Dominguez K, Jones J, et al. Validation of the HIV Pre-exposure Prophylaxis Stigma Scale: Performance of Likert and Semantic Differential Scale Versions. AIDS Behav. 2020;24(9):2637–49.CrossRefPubMedPubMedCentral Siegler AJ, Wiatrek S, Mouhanna F, Amico KR, Dominguez K, Jones J, et al. Validation of the HIV Pre-exposure Prophylaxis Stigma Scale: Performance of Likert and Semantic Differential Scale Versions. AIDS Behav. 2020;24(9):2637–49.CrossRefPubMedPubMedCentral
42.
go back to reference van Brakel WH, Cataldo J, Grover S, Kohrt BA, Nyblade L, Stockton M, et al. Out of the silos: identifying cross-cutting features of health-related stigma to advance measurement and intervention. BMC Med. 2019;17(1):13.CrossRefPubMedPubMedCentral van Brakel WH, Cataldo J, Grover S, Kohrt BA, Nyblade L, Stockton M, et al. Out of the silos: identifying cross-cutting features of health-related stigma to advance measurement and intervention. BMC Med. 2019;17(1):13.CrossRefPubMedPubMedCentral
Metadata
Title
PrEP-related stigma and PrEP use among gay, bisexual and other men who have sex with men in Ontario and British Columbia, Canada
Authors
Oscar Javier Pico-Espinosa
Mark Hull
Paul MacPherson
Daniel Grace
Mark Gaspar
Nathan Lachowsky
Saira Mohammed
James Demers
Marshall Kilduff
Robinson Truong
Darrell H. S. Tan
Publication date
01-12-2022
Publisher
BioMed Central
Published in
AIDS Research and Therapy / Issue 1/2022
Electronic ISSN: 1742-6405
DOI
https://doi.org/10.1186/s12981-022-00473-0

Other articles of this Issue 1/2022

AIDS Research and Therapy 1/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine